The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications
Abstract
BACKGROUND: Tumour control of vitreous seeds remains challenging owing to their resistance to radiation and systemic chemotherapy. OBJECTIVE: To describe the short-term efficacy of intravitreal melphalan for vitreous disease in retinoblastoma using a new injection technique and dose. METHODS: This study is a retrospective non-comparative review of 23 consecutive heavily pretreated patients (23 eyes) with active vitreous seeding and eligible for intravitreous chemotherapy (IViC). They received a total of 122 intravitreal injections of melphalan (20-30 μg) given every 7-10 days. The ocular status was objectively monitored under anaesthesia with fundus photography. RESULTS: All patients are alive without evidence of extraocular spread (95% CI 82.19% to 100%). Concomitant treatments, including other chemotherapeutic modalities, were used until complete sterilisation of the retinal seeding source and subretinal seeds. Globe retention was achieved in 87% (20/23) of cases. All retained eyes were in complete remission after a median follow-up period of 22 months (range 9-31 months). The Kaplan-Meier estimate of ocular survival rates at 2 years was 84.14% (95% CI 62.48% to 95.28%). A localised peripheral salt-and-pepper retinopathy was noted in 10 eyes (43%) at the site of injection. CONCLUSIONS: This study reports the first clinically documented case series of patients with retinoblastoma treated with IViC. Despite a possible confounding effect of concomitant chemotherapy prescription using other routes of administration in four of the successfully treated eyes (20%), IViC achieved an unprecedented success rate of tumour control in the presence of vitreous seeding. Of note, none of the treated eyes required external beam irradiation to control the vitreous seeding. Further studies are required to assess IViC retinal toxicity and to better delineate its role in the management of retinoblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review
Yousef, Y. A., Soliman, S. E., Astudillo, P. P. P., Durairaj, P., Dimaras, H., Chan, H. S. L., Héon, E., Gallie, B. L., & Shaikh, F. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0244 · Cited by 370
Self-citationMunier, F. L., Soliman, S., Moulin, A. P., Gaillard, M.-C., Balmer, A., & Beck-Popovic, M. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301016 · Cited by 224
Self-citationShields, C. L. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.4.460 · Cited by 196
Inomata, M., & Kaneko, A. (1987) · PubMed · Cited by 142
Chemotherapy for Retinoblastoma
Chan, H. Y. E., Gallie, B. L., Munier, F. L., & Popovic, M. B. (2005) · Ophthalmology Clinics of North America · doi:10.1016/j.ohc.2004.11.002 · Cited by 135
Self-citation
Cited by
Dimaras, H., Corson, T. W., Cobrinik, D., White, A., Zhao, J., Munier, F. L., Abramson, D. H., Shields, C. L., Chantada, G. L., Njuguna, F., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.21 · Cited by 553
Self-citationGlobal Retinoblastoma Presentation and Analysis by National Income Level
Global Retinoblastoma Study Group, Fabian, I. D., Abdallah, E., Abdullahi, S. U., Abdulqader, R. A., Adamou Boubacar, S., Ademola-Popoola, D. S., Adio, A., Afshar, A. R., Aggarwal, P., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.6716 · Cited by 379
Self-citationBrodowska, K., Al-Moujahed, A., Marmalidou, A., Meyer zu Horste, M., Cichy, J., Miller, J. W., Gragoudas, E., & Vavvas, D. G. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.04.011 · Cited by 220
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Pascual-Pasto, G., Bazan-Peregrino, M., Olaciregui, N. G., Restrepo-Perdomo, C. A., Mato-Berciano, A., Ottaviani, D., Weber, K., Correa, G., Paco, S., Vila-Ubach, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9321 · Cited by 118
Self-citation
Metadata
- Authors
- Munier, F. L., Gaillard, M.-C., Balmer, A., Soliman, S., Podilsky, G., Moulin, A. P., & Beck-Popovic, M.
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2012-06-13
- Volume
- 96
- Issue
- 8
- Pages
- 1078-1083
- ISSN
- 0007-1161 (ISSN-L)
- 1468-2079
- OpenAlex
- W2168914937
- Cited by
- 384
- References
- 5
- FWCI
- 20.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. https://app.cochat.ai/papers/10.1136/bjophthalmol-2011-301450
- The paper
- Munier, F. L., Gaillard, M.-C., Balmer, A., Soliman, S., Podilsky, G., Moulin, A. P., & Beck-Popovic, M. (2012). Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2011-301450
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.